Data from the 52-week follow-up of the phase III MINT trial of inebilizumab (Uplizna) in generalized myasthenia gravis was presented at the American Association of Neuromuscular & Electrodiagnostic ...

But the administrator of the Centers for Medicare & Medicaid Services (CMS), Mehmet Oz, MD, said in a post on the social ...

SAN FRANCISCO -- Two studies demonstrated the benefits of treating juvenile myasthenia gravis (MG) with newer drugs.

The resulting 124 I-evuzamitide (previously known as AT-01) has been shown to detect amyloidosis in organs like the heart, ...

While hospitals, schools, and churches were previously considered "off limits" for Immigration and Customs Enforcement (ICE) arrests, nurses are increasingly finding themselves in the middle of ...

The FDA's drug center, which Tidmarsh oversaw, has lost more than 1,000 staffers over the past year to layoffs or resignations, according to agency figures. The center is the largest division of the ...

Maine Family Planning fought the halting of Medicaid dollars in federal court, but it suffered a setback in August when a ...

A database analysis presented at the Menopause Society meeting linked the use of hormone therapy in postmenopausal women to a slightly higher risk of: True or False: A study suggested there was no ...

The trial tested two doses of claseprubart -- 300 mg and 600 mg -- and its primary endpoint was safety. Secondary outcomes ...

But last week, those words took on the force of law. On Tuesday, Texas Attorney General Ken Paxton filed a lawsuit against ...

More light in the morning and less at night is key to keeping that rhythm on schedule -- all the instruments in sync. When the clock is regularly disrupted by time changes or other reasons, he said ...

SAN ANTONIO -- Despite previous concerns, a single infusion of the nonsteroidal anti-inflammatory drug (NSAID) ketorolac alongside standard analgesics was a safe and efficacious pain control option ...